Pre-earnings options volume in Amgen is 1.6x normal with calls leading puts 5:4. Implied volatility suggests the market is anticipating a move near 3.2%, or $8.14, after results are released. Median move over the past eight quarters is 3.0%.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMGN:
- AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
- Notable companies reporting after market close
- AbbVie’s Humira drug faces competition in the U.S., FT reports
- Amgen announces Humira biosimilar now available in the U.S.
- Amgen lays off 300 employees, or 1.2% of workforce, Reuters reports
